NEJMÊÙ¶¯²ñ2003  Âè12²ó 03/04/23¼Â»Ü  A¥×¥ê¥ó¥È  Ã´Åö¡§Æ£ÅÄ  Âç»Ê
Case 3-2003  A 36-Year-Old Man with Renal failure, Hypertension, and Neurologic Abnormalities  (Volume348:333-342)
-¿ÕÉÔÁ´¡¦¹â·ì°µ¡¦¿À·Ð³ØŪ°Û¾ï¤ò¸«¤é¤ì¤¿36ºÍÃËÀ­-

 
¡Ú¸½ÉÂÎò¡Û36ºÐ¡¢±¦Íø¤­¤ÎÃËÀ­¤¬È¯ºî¤È½ÅÅ٤ιâ·ì°µ¤ò¼çÁʤËÆþ±¡¤·¤¿¡£
  ´µ¼Ô¤Ï²áµî¤Ë¡¢18ǯ´Ö¤Ë¤ï¤¿¤ëÌôʪ»ÈÍÑÎò¡ÊÀÅÌ®ÆâÃí¼Í¡¢Ãí¼Í¿Ë¤Î¶¦ÍÑ¡¢¥Ø¥í¥¤¥ó¡¢¥³¥«¥¤¥ó¡Ë¤¬¤¢¤ë¡£
  Æþ±¡£±Ç¯Á°¤ËÉÔÀµÌôºÞ¤Î»ÈÍѤò¤ä¤á¤¿¤È¤³¤í¡¢ÂÎÄ´¤¬¤¹¤°¤ì¤Ê¤¯¤Ê¤Ã¤¿¤³¤È¤¬¤¢¤ë(vaguely unwell)¡£
  Æþ±¡3¥õ·îÁ°¡¢º¸Â­»Ø¤Ë¤Ò¤ê¤Ò¤ê¤·¤¿´¶¤¸¤¬À¸¤¸¡¢Ëãá㤷¤Æ¤­¤¿¡¨¤³¤Î¤È¤­¡¢È¿ÉüÀ­¤ÎÓÒÅÇ¡¢Åð´À¡¢´Ö·çŪ¤Ê²¼Î¡¡¢Ê¢ÉôÄË¡¢È¯Ç®¡Ê¼«³Ð¤µ¤ì¤ëÄø¤Î¤â¤Î¡Ë¡¢ÂνŸº¾¯ (16 ­Ô) ¤âǧ¤á¤Æ¤¤¤ë¡£¤¹¤Í¤«¤é­¼ó¤Ë¤«¤±¤Æ¤Î¹ÈÈÃÀ­Ïµáì¤Ëµ¤ÉÕ¤¤¤¿¡¨¤½¤ì¤Ï¼£Ìþ¤¹¤ë¤Þ¤Ç£±¥õ·î¤Î´Ö¡¢Á²Áý¡¦Á²¸º¤·¤¿¡£
  Æþ±¡£µ½µÁ°¡¢Ê̤Îɱ¡¤Ë¤«¤«¤ê¡¢¹â·ì°µ¤È¿ÇÃǤµ¤ì¤¿¡£¤³¤ÎºÝ¡¢B·¿¡¦C·¿´Î±ê¤Î¸¡ºº¤ò¼õ¤±¡¢ÍÛÀ­¤È¤Ê¤Ã¤Æ¤¤¤¿¡£Èó·Ð¸ý±ÉÍܤˤÆÂн褵¤ì¡¢3½µ´Ö¤·¤ÆÂౡ¤È¤Ê¤Ã¤Æ¤¤¤ë¡£
  £±½µ´Ö¸å¡¢º¸µÓ¤Î¿Ì¤¨¤¬À¸¤¸¡¢º¸ÏӤ˹­¤¬¤Ã¤Æ¤­¤¿¡£°Õ¼±¤ò¼º¤¤¡¢¶¯Ä¾À­´ÖÂåÀ­È¯ºî¤È¤Ê¤Ã¤¿¡££²¤ÄÌܤÎɱ¡¤Ø¤È±¿¤Ð¤ì¡¢È¯ºî¤¬ºÆÅÙǧ¤á¤é¤ì¤¿¤Î¤Ç¥Õ¥§¥Ë¥È¥¤¥óNa¤È¥Ù¥ó¥¾¥¸¥¢¥¼¥Ô¥ó¤Ë¤Æ¼£ÎŤµ¤ì¤¿¡£Æþ±¡»þ¤Î·ì°µ¤Ï 240/130mmHg ¤Ç¤¢¤Ã¤¿¡£Ç¢¤Ë°Û¾ï¤Ïǧ¤á¤é¤ì¤Ê¤«¤Ã¤¿¡£·ì±Õ¸¡ºº¤Î·ë²Ì¤òtable 1¤È2¤Ë¼¨¤¹¡£ECG¤Ë¤ÆƶÀ­ÉÑÌ®¤ÈÁ´Í¶Æ³¤Ë¤ª¤±¤ëÈóÆðÛŪST¤ÈTÇȤξ徺¤¬¸«¤é¤ì¤¿(sinus tachycardia and diffuse, non-specific ST- and T- wave abnormalities)¡£¿ñ±Õ½ê¸«¤Ç¤ÏºÙ˦À®Ê¬¤òǧ¤á¤º¡¢ÇÝÍܤˤƤⲿ¤âÀ¸¤¨¤Ê¤«¤Ã¤¿¡¨Åü 59 mg/ml (3.3 mmol/l) ¡¢¥¿¥ó¥Ñ¥¯ 71mg/dl ¤Ç¤¢¤Ã¤¿¡£Æ¬ÉôCT¤Ç¤ÏƬ³¸Æâ½Ð·ì¤Î·ÁÀפϸ«¤é¤ì¤Ê¤«¤Ã¤¿¡£Æ¬ÉôMRI¤Ç¤Ï¸åƬÉô¤ËÄã°­À­Å٤ο·À¸Êª¤È¤ª¤Ü¤·¤­¤â¤Î¤¬¸«¤é¤ì¤¿ ( A cranial magnetic resonance imaging study was believed to have suggested the presence of a low-grade occipital neoplasm.)¡£
  ¥é¥Ù¥¿¥í¡¼¥ë¡¢¥¯¥í¥Ë¥¸¥ó¡¢Í¢±Õ¡¢ÅŲò¼Á¤¬ÅêÍ¿¤µ¤ì¡¢¹â·ì°µ¤Ï¤ª¤µ¤Þ¤Ã¤¿¡£Æþ±¡£µÆüÌܤˡ¢¥Õ¥§¥Ë¥È¥¤¥ó¡¢¥é¥Ù¥¿¥í¡¼¥ë¡¢¥¯¥í¥Ë¥¸¥ó¡¢¥È¥é¥¾¥É¥ó¡¢¥Ö¥×¥í¥Ô¥ª¥ó¡¢¥ª¥á¥×¥é¥¾?¥ë¡¢±ö²½¥«¥ê¥¦¥à¡¢(phenytoin. Labetalol, clonidine, trazodone, bupropion, omeprazole, potassium choloride)¤ò½èÊý¤µ¤ì¤ÆÂౡ¤·¡¢³°Íè¤Ë¤Æ¥Õ¥©¥í¡¼¤¹¤ë¤³¤È¤È¤Ê¤Ã¤¿¡£¤È¤³¤í¤¬¡¢Âౡ¤¹¤°¤·¤Æº¸Â­¤È­¼ó¤Îáã¤ì¤È¡Ö»É¤¹¤è¤¦¤ÊÄˤߡפò´¶¤¸¤ë¤è¤¦¤Ë¤Ê¤ê¡¢°Û¾ï´¶³Ð dysesthesia¤òȼ¤¦¤è¤¦¤Ë¤Ê¤Ã¤¿¡£¶É½ê¤Î¶ÚÎÏÄã²¼¤¬½Ð¸½¤·¤Æ¤­¤¿¤¬¡¢²¼ÇØÉô¤äºÁ¹ü¤Ë¤ÏÄˤߤϤʤ«¤Ã¤¿¡£Âౡ3ÆüÌܤˤ·¤Æ¡¢Åö±¡¤ØÆþ±¡¤È¤Ê¤Ã¤¿¡£
  ´µ¼Ô¤ÏÂç³Ø¤Ç¤Î²ñ·×·¸¤Ç¤¢¤ë¡££¸Ç¯Á°¤ËHIV¸¡ºº¤Ë¤ÆÍÛÀ­¤È¤Ê¤Ã¤¿¤È¸À¤¦¤¬¡¢¤½¤Î¸å¤Î¸¡ºº¤Ç¤Ï±¢À­¤È¤Î¤³¤È¡£¥¢¥ë¥³¡¼¥ëÍðÍѤδû±ý¤¬¤¢¤ë¤¬¡¢15ǯÁ°¤Ë¤­¤Ã¤Ñ¤ê¤È¤ä¤á¤¿¡££±Æü¤Ë±ìÁð¤òȾ¥Ñ¥Ã¥¯µÛ¤¦¡£Æ¬ÄË¡¢»ëÌî¾ã³²¡¢È¯´À¡¢´Ö·çŪȯǮ¡¢ÇÙÉôÄˤ¬¤¢¤Ã¤¿¤³¤È¤òµ­²±¤·¤Æ¤¤¤ë¤¬¡¢¤¤¤Ä¡¦¤É¤ì¤¯¤é¤¤¤Î´Ö¤«¤Ï³Ð¤¨¤Æ¤¤¤Ê¤¤¡£ÇØÉô¤Î³°½ý¤ä·ìÊØÇÓÝõ¡¢²¼·ì¤Ïº£¤Þ¤Ç¤Ê¤«¤Ã¤¿¡£
 
¡Ú¸½¾É¡Ûadmission on foot
<vital> BT 36.1¡î, PR 96, RR 20, BP 185/110mmHg
<general appearance> Á餻¤Æ¤ª¤ê¡¢Ç¯Îð¤è¤êÏ·¤±¤Æ¸«¤¨¤¿¡£
<skin> ¤¹¤Í¤«¤é­¼ó¤Ë¤«¤±¤Æ¡¢Ã㿧¤¤ÈÃÅÀ¾õ¤Î¿§ÁÇÄÀÃå¤È2?5mm·Â¤Î±ú¤ó¤À¿§ÁǤεõ椢¤ê
<head> ¾®¤µ¤Ê·ÛÉô¥ê¥ó¥ÑÀá¤ò¤¤¤¯¤Ä¤«¿¨¤ì¤ë
<heart><lung>  Ä°¿Ç¤Ë¤Æ¶»Éô¤Ë°Û¾ï¤òǧ¤á¤º
<abdomen>  splenic tip ¤ò¿¨¤ì¤ë
<extremities>  Éâ¼ð¤Ï¤Ê¤¤
 
<nuerological>  ¸«Åö¼±¤Ï¤Ï¤Ã¤­¤ê¤È¤·¡¢µ­²±¡¦Ç§Ãξ㳲¤Ï¤Ê¤¤¡£Æ·¹¦¤Ëº¸±¦º¹¤Ï¤Ê¤¤¡£¾åÊý»ë¤Ë¤ÆξÌܤˤ鷺¤«¤Ë¿âľÊý¸þ¤Î´ã¿¶¤¢¤ê¡£ÄÉ»ë¾ã³²¤òǧ¤á¤ë¤¬¡¢¥µ¥Ã¥±¡¼¥É¤ÏÊݤ¿¤ì¤Æ¤¤¤ë¡£Drift ¤Ï¤Ê¤¤¡£
MMT¡§ left hamstring 5/5, left quadriceps 5/5, left gastrocnemius 2/5¡¢¤½¤Î¾¤Ï¤¹¤Ù¤Æ5/5¡£¶Ú¶ÛÄ¥¤ÏÀµ¾ï¤Ç¡¢°Ñ½Ì¤ä°Û¾ï±¿Æ°¤Ï¤Ê¤¤¡£
¿¨³Ð¡¢Ä˳С¢²¹ÅٳФϺ¸Â­¤Î³°Â­¤È¿Æ»Ø¤ÎÉÕ¤±º¬¤ÇÄã²¼¤·¤Æ¤¤¤¿( lateral aspect and ball of the foot)¡£º¸Â­¤ÎÃæÉô¤Ç¤Ï¤µ¤é¤ËÄã²¼¤·¤Æ¤¤¤¿¡£¿¶Æ°³Ð¤ËÌäÂê¤Ï¤Ê¤¯¡¢Â­¼ó°Ê¾å¤Î´¶³Ð¤ÏÀµ¾ï¤Ç¤¢¤Ã¤¿¡£
ìû¤¹¤Í»î¸³¤ÏÇpoor ¤À¤Ã¤¿¤â¤Î¤Î¡¢¶¨Ä´±¿Æ° coordination ¤ÏÀµ¾ï¤Ç¤¢¤Ã¤¿¡£Êâ¹Ô¤Ï antalgic ¡ÊÄÃÀÅŪ¡©¡Ë ¤Ç¤¢¤ê¡¢º¸Â­¤ò¤«¤Ð¤Ã¤Æ¤¤¤¿¡£Î¾ìû¤È±¦¤Ä¤ÞÀè¤ÇΩ¤Ä¤³¤È¤Ï¤Ç¤­¤¿¤¬¡¢º¸¤Ä¤ÞÀè¤Ç¤Ï̵Íý¤À¤Ã¤¿¡£Romberg ¤Ï±¢À­¡£¼ºÄ´¤Ê¤¯¥Ù¥Ã¥É¤Îü¤ËºÂ¤ë¤³¤È¤Ï¤Ç¤­¤¿¡£DTR¤Ï¡¢Î¾ÏÓ¤Ï+¡¢É¨¤È±¦Â­¼ó¤Ï2+¡¢º¸Â­¼ó¤Ç¤Ï¾Ã¼º¤·¤Æ¤¤¤¿¡£Â­ÄêÉôÈ¿¼Í¤Ï flexor ¤Ç¤¢¤Ã¤¿
<urine> pro (3+), glu (¤«¤¹¤«¤Ë+), WBC 0?2/LPF, RBC 0/LPF
<·ì»»>  Ht 38.8%, Hb 16.3¡ÊÆþ±¡£±½µ´ÖÁ°¡Ë, MCV 84, WBC 14000 ( Neu 76 Lym 17 Mono 3 Eos 3 Baso 1), Reti 3%, plt 415000, ESR 107,¡Êtable 1»²¾È¡Ë
<À¸²½>  TP 7.3,g/dl Alb 2.0 g/dl, Na 132 mEq/l, K 3.3 mEq/l, Cl 91 mEq/l, CO2 27.3, BUN 35 mg/dl, Cre 2.7 mg/dl, ALP 376 U/l, GOT 83 U/l, LDH 470 U/dl¡Êtable 2»²¾È¡Ë
toxic agents ¤Î¸¡º÷¤Ç¤Ï¡¢Ç¢À¸²½¤Ë¤Æ¥Ð¥ë¥Ó¥Ä¡¼¥ë¤ò¸¡½Ð¤·¤¿¤Î¤ß¤Ç¤¢¤Ã¤¿¡£
 
<ECG> normal rhythm, rate 79/min, left ventricular hypertrophy ¤¢¤ê
<sero> syphilis (-)
 
<ƬÉôMRI>  Ç¯ÎðÉÔÁê±þ¤Î mild atrophy¡£T£²¤Ë¤Æ increased signal density in the right periatrial white matter, right forceps major, and left parietal cortical and subcortical white matter ¤òǧ¤á¤¿¤¬¡¢¥°¥ê¥ª¡¼¥·¥¹¤«ÈùºÙºÉÀò¾É¤òȼ¤¦µõ·ìÀ­ÊѲ½¤Ë¤è¤êµ¯¤­¤¦¤ë¤â¤Î¤Ç¡¢ÈóÆðÛŪ¤Ç¤¢¤Ã¤¿¡£Mass¤ä°Û¾ï¤Ê¤±Æ¸ú²Ì¤Ïǧ¤á¤Ê¤«¤Ã¤¿¡£ Diffusion-weighed sequence ¤Ç¤ÏµÞÀ­¹¼ºÉ¤Îº¯ÀפϤʤ¯¡¢flow void ¤ÏÀµ¾ï¤Ç¤¢¤Ã¤¿¡£
 
<·Ð¶»ÊÉ¿´¥¨¥³¡¼>  Á°Àí¤òÃæ¿´¤È¤·¤¿MÊۤΤӤޤóÀ­¤ÎÈî¸ü¤òǧ¤á¤ë¡£½ê¸«¤ÏÊÛËì±ê valvulitis¤ä vegitation ¤ÈÌ·½â¤·¤Ê¤¤¡£Mild MR¤ò¥«¥é¡¼¥É¥Ã¥×¥é¡¼¤Ë¤Æǧ¤á¤ë¡£LV¤Ï¤ï¤º¤«¤Ë³ÈÄ¥¤·¤Æ¤¤¤ë¤¬¡¢ÌÀ¤é¤«¤ÊÊɱ¿Æ°¤Î°Û¾ï¤Ï¤Ê¤¤¡£EF 54%¤Ç¤¢¤Ã¤¿¡£
 
¡ÚÆþ±¡¸å·Ð²á¡Û
  ¥Õ¥§¥Ë¥È¥¤¥ó¡¢¥¯¥í¥Ë¥É¥ó¡¢¥é¥Ù¥¿¥í¡¼¥ë¡¢¥Ë¥Õ¥§¥¸¥Ô¥ó¡¢¥Ø¥Ñ¥ê¥ó¡¢¥Ö¥×¥í¥Ô¥ª¥ó¡¢¥È¥é¥¾¥É¥ó¡¢±ö²½¥«¥ê¥¦¥à¡¢¥³¥Ç¥¤¥ó-¥¢¥»¥È¥¢¥ß¥Î¥Õ¥§¥ó¡Êphenytoin, clonidone, labetalol, nifedipine, ¾¯ÎÌ heparin, bupropion, trazodone, potassium chloride, codeine-accetaminophen¡Ë ¤ò½èÊý¤µ¤ì¤¿¡£Âβ¹¤Ï¾ï»þ¡¢Àµ¾ï¤Ç¤¢¤Ã¤¿¡£Æþ±¡¤«¤é3Æü´Ö¡¢·ì°µ¤Ï¬Äꤹ¤ëÅ٤˾夬¤Ã¤Æ¤¤¤¿¡£ºÇ¹âÃÍ¤Ï 180/140 mmHg¡£´Ö·çŪ¤ËÓÒÅǤ¬¤¢¤Ã¤¿¤¬¡¢ÅÇ·ì¤Ï¤Ê¤«¤Ã¤¿¡£
  Æþ±¡£²ÆüÌܤ˿À·Ð´ã²Ê¡©(neuro-ophthalmologic)¤Ë¥³¥ó¥µ¥ë¥¿¥ó¥È¤·¤¿¤È¤³¤í¡¢»ë¿À·ÐÆýƬÉâ¼ð¤ò»ØŦ¤µ¤ì¤¿¡Êξ´ã¤ÎÆýƬ¤ÎÉÔÁ¯ÌÀ²½¤Èº¸´ã¤ÎÌʲÖÍÍÉÂÊÑ cotton-wool spots¡Ë¡£ÌôºÞ¤Ë¤è¤ë³ÈÄ¥¤Î¤¿¤áÆýƬȿ¼Í¤Ï¤È¤ì¤º¡£
  ¹â·ì°µ¤Î¥³¥ó¥È¥í¡¼¥ë¤Î¤¿¤á¡¢ICU¤Ë°Ü¤ë¡£¿ÈÂν긫¤ËÊѲ½¤Ï¤Ê¤¯¡¢»¨²»¤Ê¤É¤ÏÄ°¼è¤·¤Ê¤«¤Ã¤¿¡£À¸²½³Ø¸¡ºº¤¬»Ü¹Ô¤µ¤ì¤¿(table 1&2)¡£¥¿¥ó¥Ñ¥¯Ç¢(4+)¤¬¤¢¤ê¡¢ÄÀºº¤ÇÊÑ·ÁÀÖ·ìµå¤Èµ©¤ÊºÙ˦±ßÃì¤òǧ¤á¤¿¡£Ê¢Éô¥¨¥³¡¼¤Ë¤Æ¡¢±¦ 10.8cm, º¸ 12.8cm¤Ç¤¢¤Ã¤¿¡£Èé¼Á¤Î¹â¥¨¥³¡¼¤òǧ¤á¤ë¤â¤Î¤Î¡¢¿å¿Õ¾É¤Ï¤Ê¤¯¡¢ÁãÉÂÊѤϤʤ«¤Ã¤¿¡£ç£Â¡¤Ï¤ä¤äÈîÂ礷¤Æ¤ª¤ê¡¢Ê¢¿å¤¬¾¯Î̤¢¤Ã¤¿¡£
  Æþ±¡3ÆüÌܤˤϵ¤Ê¬¤¬Îɤ¯¤Ê¤Ã¤Æ¤­¤¿¡£Æ¬ÄˤϤʤ¯¤Ê¤ê¡¢°­¿´¡¦ÓÒÅǤâ¤Ê¤¯¤Ê¤Ã¤¿¡£·ì°µ¤Ï 150/70 - 170/100 mmHg¤Ç¿ä°Ü¤·¤Æ¤¤¤¿¡£Room air ¤Ë¤Æ PO2 95mmHg, PCO2 44mmHg, pH 7.42 ¤Ç¤¢¤Ã¤¿¡£ASO(-), Anti-DeoxyriboNucleases B (-)¡£Ç¢¸¡ºº¤Ç¤Ï¡¢¥¯¥ì¥¢¥Á¥Ë¥ó 96mg/dl, ¥¿¥ó¥Ñ¥¯ 8030 mg/l ¤Ç¤¢¤Ã¤¿¡£¶»ÉôXÀþ¤Ç°Û¾ï¤Ïǧ¤á¤º¡£Ê¢Éô¥¨¥³¡¼¤Ë¤ÆÃÀǹ¤ÏËÄÄ¥¤·¤Æ¤ª¤ê¡¢ÃÀÀФ¬¤¢¤Ã¤¿¤¬¡¢ÃÀǹ±ê¤Ï¤Ê¤«¤Ã¤¿¡£´Î¡¤ÏÀµ¾ï¤Ç¤¢¤ê¡¢ç£Â¡¤ËÆä˰۾ï¤Ï¤Ê¤«¤Ã¤¿¡£¿Õ¡¤Î½ê¸«¤Ï°ÊÁ°¤ÈÊѤï¤é¤º¡£¹øÄǤΥ¬¥É¥ê¥Ë¥¦¥àMRI¤Ç¤ÏL5¤ÈS1¤Î´Ö¤ÎÄÇ´ÖÈĤΤ鷺¤«¤ÊÆͽФòǧ¤á¤ë¤¬¡¢L5¤ÎÀÔÄǤ¹¤Ù¤ê¾É¤Ï¤ï¤º¤«¤Ç¤¢¤ê¡¢ÀÔÄǹŲ½¡¦ÄÇ´ÖÈıꡦ¹ü¿ñ±ê¡¦Ç¿áç¤Îº¯Àפϸ«¤é¤ì¤Ê¤«¤Ã¤¿¡£
  Æþ±¡£´ÆüÌܤˤϡ¢·Ð¸ý¹ß°µºÞ»ÈÍѲ¼¤Ç·ì°µ¤Ï 150.90 mmHg ¤Ç¤¢¤Ã¤¿¡£½é¤á¤Îɱ¡¤«¤é¤Î¥Ç¡¼¥¿¤Ç¤Ï¡ÊÉÔ´°Á´¤Ê¤â¤Î¤Ç¤¢¤Ã¤¿¤¬¡ËÇ¢ÁÇÃâÁǤȥ¯¥ì¥¢¥Á¥Ë¥ó¤ÏÀµ¾ï¤È¤Î¤³¤È¤À¤Ã¤¿¡£HBs Ag(+) HBs Ab(-) ¤¬³Îǧ¤µ¤ì¤¿¡£IgM HAV ab ¤Ï±¢À­¤Ç¤¢¤Ã¤¿¡£HCV ab (+)¤Ç¤â¤¢¤Ã¤¿¡£·Ð¿©Æ»¿´¥¨¥³¡¼¤Ç¤Ï·Ð¶»ÊÉ¿´¥¨¥³¡¼¤Î½ê¸«¤È°ìÃפ·¤¿¡£
  Æþ±¡£µÆüÌܤˤϷì±Õ¸¡ºº¤¬»Ü¹Ô¤µ¤ì¤¿¡Êtable 2¡Ë¡£ÍÕ»À¡¦Vit B12 ¤ÏÀµ¾ï¤Ç¤¢¤Ã¤¿¡£·ì±ÕÇÝÍܤϣ¶¤Ä¤È¤â±¢À­¤Ç¤¢¤Ã¤¿¡£ HIV 1/2 Ab¤Ï±¢À­¤Ç¤¢¤ê¡¢rtPCR¤Ç¤Ï HIV-1 RNA ¤Ï¸¡½Ð¤µ¤ì¤Ê¤«¤Ã¤¿¡£HBsAg(+), HBsAb(-), HCV ab(+), ANCA(-)¡£¥Ï¥×¥È¥°¥í¥Ö¥ê¥ó¡¢ÊäÂÎ,C3,C4¤Ï¤¤¤º¤ì¤âÀµ¾ï¤Ç¤¢¤Ã¤¿¡£
 
¤¢¤ë¿ÇÃÇŪ¼êµ»¤¬»Ü¹Ô¤µ¤ì¤¿¡£